Carbon monoxide poisoning: investigations and treatment

A brief history of carbon monoxide and its therapeutic origins

It is estimated that 10% of carbon throughout the cosmos is in the form of carbon monoxide (CO). Earth's earliest prebiotic atmosphere included the trinity of gasotransmitters CO, nitric oxide (NO), and hydrogen sulfide (H₂S), for which all of life has co-evolved with. The history of CO can be loosely traced to mythological and prehistoric origins with rudimentary understanding emerging in the middle ages. Ancient literature is focused on CO's deadly toxicity which is understandable in the context of our primitive relationship with coal and fire. Scientific inquiry into CO appears to have emerged throughout the 1700s followed by chemical and toxicological profiling throughout the 1800s. Despite CO's ghastly reputation, several of the 18th and 19th century scientists suggested a therapeutic application of CO. Since 2000, the fundamental understanding of CO as a deadly nuisance has undergone a paradigm shift such that CO is now recognized as a neurotransmitter and viable pharmaceutical candidate. This review is intended to provide a brief history on the trace origins pertaining to endogenous formation and therapeutic application of CO.

Rapid elimination of CO through the lungs: coming full circle 100 years on

At the start of the 20th century, CO poisoning was treated by administering a combination of CO(2) and O(2) (carbogen) to stimulate ventilation. This treatment was reported to be highly effective, even reversing the deep coma of severe CO poisoning before patients arrived at the hospital. The efficacy of carbogen in treating CO poisoning was initially attributed to the absorption of CO(2); however, it was eventually realized that the increase in pulmonary ventilation was the predominant factor accelerating clearance of CO from the blood. The inhaled CO(2) in the carbogen stimulated ventilation but prevented hypocapnia and the resulting reductions in cerebral blood flow. By then, however, carbogen treatment for CO poisoning had been abandoned in favour of hyperbaric O(2). Now, a half-century later, there is accumulating evidence that hyperbaric O(2) is not efficacious, most probably because of delays in initiating treatment. We now also know that increases in pulmonary ventilation with O(2)-enriched gas can clear CO from the blood as fast, or very nearly as fast, as hyperbaric O(2). Compared with hyperbaric O(2), the technology for accelerating pulmonary clearance of CO with hyperoxic gas is not only portable and inexpensive, but also may be far more effective because treatment can be initiated sooner. In addition, the technology can be distributed more widely, especially in developing countries where the prevalence of CO poisoning is highest. Finally, early pulmonary CO clearance does not delay or preclude any other treatment, including subsequent treatment with hyperbaric O(2).

The combined effect of heat and carbon monoxide on the performance of motorsport athletes

Two of the major stressors endured by a motorsport athlete (MSA) during a racing event are the effects of heat and carbon monoxide. To date, there has been little research into their combined effect on driving performance. Using an interactive racecar simulator located within an environmental chamber, subjects drove a simulated race (60 min) in environmental conditions similar to those that develop during a NASCAR Winston Cup oval track race (50 degrees C ambient temperature and 10-12% carboxyhaemoglobin levels). Subjects also completed cool (20 degrees C) and heat only (50 degrees C) race simulations. During the simulations, oxygen consumption, heart rate, core and skin temperatures and psychomotor performance were measured. The results demonstrated that exposure to a racecar micro-environment combining both heat and CO produced significantly greater (P<0.05) sweat loss and core temperature change (1.53 kg; 1.06 degrees C) when compared to the heat only (1.14 kg; 0.73 degrees C) and cool conditions (0.35 kg; 0.09 degrees C). Furthermore, a significant decrease (P<0.05) in psychomotor performance was also shown between the heat/CO condition (contact points=38), and both the heat only (25 points) and cool conditions (22 points). It follows that lengthy exposure to these two stressors could produce a substantial decrement in driving performance, thereby endangering the MSA and other race competitors.

A simple "new" method to accelerate clearance of carbon monoxide

The currently recommended prehospital treatment for carbon monoxide (CO) poisoning is administration of 100% O(2). We have shown in dogs that normocapnic hyperpnea with O(2) further accelerates CO elimination. The purpose of this study was to examine the relation between minute ventilation (V E) and the rate of elimination of CO in humans. Seven healthy male volunteers were exposed to CO (400 to 1,000 ppm) in air until their carboxyhemoglobin (COHb) levels reached 10 to 12%. They then breathed either 100% O(2) at resting V E (4.3 to 9.0 L min) for 60 min or O(2) containing 4.5 to 4.8% CO(2) (to maintain normocapnia) at two to six times resting V E for 90 min. The half-time of the decrease in COHb fell from 78 +/- 24 min (mean +/- SD) during resting V E with 100% O(2) to 31 +/- 6 min (p < 0. 001) during normocapnic hyperpnea with O(2). The relation between V E and the half-time of COHb reduction approximated a rectangular hyperbola. Because both the method and circuit are simple, this approach may enhance the first-aid treatment of CO poisoning.

Carbon monoxide poisoning

Carbon monoxide is a common domestic and industrial poison which may be lethal. Survivors can develop permanent neuropsychiatric disability. The mechanisms of toxicity are poorly understood and the traditional criteria used to determine the severity of the poisoning have low predictability. Oxygen is the recommended antidote to carbon monoxide, but it appears that oxygen under hyperbaric conditions repeated either daily or as indicated by the patient's condition may be required to provide an effective dose. A reliable marker of the severity of carbon monoxide poisoning is urgently needed so that trials of alternative regimens can proceed.

Prevention, diagnosis and treatment of carbon monoxide poisoning in an East-Slovakian ironworks

The development of industry brings an increase in number of industrial poisonings by carbon monoxide. To treat these the East-Slovakian Ironworks has organised preventive measures. Instructive cases are illustrated. Measurement of carbon monoxide--haemoglobin in the laboratory gives an objective index for the degree of poisoning and the progress of treatment. The authors used cobaltous nitrate (0.13 mol/l) for control of the method. The best treatment was found to be hyperbaric oxygen in combination with multi-vitamin treatment. In some cases cardiorespiratory and antibiotic treatment is also necessary.

Use of a one-man, mobile pressure chamber in the treatment of carbon monoxide poisoning

For the past five years a mobile pressure chamber has been used to treat patients suffering from severe carbon monoxide poisoning with oxygen at 2 atmospheres pressure. Of the 25 patients treated, 20 recovered completely and only three died. This apparatus could also be used for hyperbaric oxygen therapy in other conditions for which it is indicated.